Wereport a 27-year-old manwith insulin-dependent diabetes mellitus and transient-pituitary-isolated gonadotropin deficiency. He had typical diabetic symptoms, and a loss of libido of a 6-month duration. Although antibodies to islet cells or islet cell surface were not detected in his sera, daily urinary excretion of c-peptide immunoreactivity was extremely low, and antibodies to the pituitary AtT-20 cell were detected. The plasma responses of gonadotropin to a single and a repetitive lute-nizing hormone-releasing hormone were extremely low, whereas testosterone concentrations in the serum and urine were low normal. After 6 months, the gonadotropin deficiency and loss of libido were not detected and antibodies to the AtT-20 cell was negative. We suspected that both insulin-dependent diabetes mellitus and transient-gonadotropin-deficiency might be an autoimmune mechanism. (Internal Medicine 33: 27-30, 1994) 
Introduction
Diabetes mellitus is divided into two subtypes according to the patients ' dependency for survival on treatment with insulin ( 1 ) : insulin dependent (IDDM) and non-insulin-dependent diabetes mellitus. Autoimmunityis largely responsible for IDDM (2) . Somepatients with IDDMhave multiple endocrine organ involvement at a subclinical level and their sera contain organspecific antibodies (3) . Indeed, IDDMis not infrequently seen in association with other known endocrine disorders, such as Schmidt's syndrome, a thyrogastric autoimmune disease.
However, there is, according to a literature search, no report which suggests an association of IDDMwith transient-pituitary-isolated gonadotropin deficiency. Wereport here the first such case with a combination of the two disorders.
Case Report
A 27-year-old manwas admitted to our hospital because of thirst, general fatigue, and a weight loss of29 kg which occurred during the previous 6 months. On admission, he also complained of a loss of libido. On physical examination, he appeared in good proportion with a weight of 62.0 kg and height of 169.5 cm. Blood pressure was 132/70 mmHgand pulse rate was 72 beats per minute and regular. Olfactory sensation was normal. Axillary temperature was 36.2°C. The thyroid gland was not palpable. No cardiac murmurnor rales were heard in the chest. His skin was slightly dry. Axillary and inguinal hair were normal in appearance and his testes were normal in size and consistency. Neurological examinations revealed no abnormalities.
Urinalysis revealed glucosuria and ketonuria. His plasma glucose level and hemoglobin Alc were 415 mg/dl and 21.1%, respectively. Daily urinary excretion of C-peptide immunoreactivity (CPR) was low (10.3 jig/day). Therefore, he was treated with a subcutaneous injection of crystalline insulin and saline infusion immediately after admission. Blood count and serum chemistry were within normal limits. Liquor analysis and semenanalysis werealso normal. Human leukocyte antigen (HLA) analysis revealed positive Bw59 and DR4.
Endocrinological examinations were done after an overnight fast when his glycemic control was improved by daily insulin injections and diet modification. Plasma thyroid-stimulating hormone (TSH) responses to thyrotropin releasing hormone (TRH) (4) ( Table  1A) , and responses of the adrenocorticotropic hormone (ACTH) and growth hormone and 17-ketosteroid to ACTH(7), which was given i.v. at a dose of 1 mg daily for 3 consecutive days (Table 2A) , were normal. The serum luteinizing hormone (LH) and follicle stimulating hormone (FSH) did not respond to the LH-releasing hormone (LH-RH), which was administered either by a single i.v. or by a repetitive daily i.v. injection for 7 consecutive days (8, 9) ( Table 2B and 2C). Daily urinary excretion of testosterone and the plasma testosterone level were low normal (18 JLig/day and 2.8 ng/ml, respectively). LHand FSH responses to LH-RH were improved to nearly normal 6 months later (Fig. 1) , when he had a normal libido and was in good glycemic control. Daily urinary CPR excretion was, however, still low (14.8 jig/day). A skull X-ray revealed no enlargement of the sella turcica and no destruction of the posterior clinoid process (Fig. 2) . Magnetic resonance imaging (MRI) showed pituitary atrophy on the bottom of the sella turcica associated with an empty sella ( ( 1 1) 
Discussion
Although ICA and ICSA were not detected in the patient's sera, diagnosis of this patient was IDDMbecause of the sudden onset (to date, no glucosuria in his annual examinations), young age, low daily urinary CPRexcretion, associated ketosis, and positive HLADR4. As it has been reported that these two antibodies are negative in 35%of IDDM cases at onset and in 80% 2 years post onset (15), failure to detect ICA and ICSA does not exclude the possibility that the present patient had IDDM.
The normal responses of TSH to TRHand of cortisol to insulin-induced hypoglycemia and ACTH suggest no abnormalities in the hormonal relationship between the pituitary and the thyroid or adrenal glands in the present case. In addition, changes in GHduring insulin-induced hypoglycemia were normal. In contrast, the responses ofLH and FSHto a single iv LH-RHinjection were extremely low. Further, the responses were also low even when measured after repetitive i. Eller and Winternitz found pituitary dysfunction in patients with diabetes mellitus ten times more frequently than in the non-diabetic population ( 1 6). They speculated that this was due to ischemic changes caused by vascular complication in diabetes mellitus. In the present patient, however, this is not the case because he is 27 years old and has no triopathy of diabetes mellitus. The coexistence ofIDDMwith a pituitary gonadotropin deficiency, as well as the simultaneous onset of the two disorders in the present case, suggests that there might be immunemediated destruction of the endocrine pancreas and the pitui- Hashimoto's disease (21), and hypopituitarism (22-25). It is, however, unlikely that the present patient had autoimmune thyroid disease because autoantibodies against thyroglobulin and thyroid peroxidase were not detected and his thyroid gland was not enlarged or atrophied. Another point of interest is that gonadotropin secretion resumed 6 months later, with no detection of antibodies to the pituitary AtT-20 cell after good glycemic control with insulin treatment was established. To our knowledge, this is the first case reported of IDDMwith transient-pituitary-isolated gonadotropin deficiency.
